This Darden Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
Top Wall Street analysts changed their outlook on top names. See analyst ratings page for full list. DRI, JANX, and more mentioned.
Stocks · News reference
Barclays Maintains Overweight on Celestica, Lowers Price Target to $406
Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and lowers the price target from $430 to $406.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Upgrades Celestica to Buy, Raises Price Target to $430
UBS analyst David Vogt upgrades Celestica (NYSE:CLS) from Neutral to Buy and raises the price target from $410 to $430.
Micron and 15 Other Stocks To Play The AI Buildout Race: They Are Still 20% Below Highs
Bank of America screened its AI baskets for Buy-rated stocks down over 20% from highs. Micron carries the widest gap to target.
Scotiabank Reinstates Sector Outperform on Celestica, Announces $500 Price Target
Scotiabank analyst Kevin Krishnaratne reinstates Celestica (NYSE:CLS) with a Sector Outperform and announces $500 price target.